• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 758

Lactobacillus helveticus R0052, Bifidobacterium longum subsp. infantis R0033, and Bifidobacterium bifidum R0071

Intended Use: For use, both individually and in combination, as an ingredient of powdered infant formulas at 5 x 107 cfu/g of powder in formulas with hydration rates of 12.5 to 13/5 g/100 ml.
Basis: Scientific procedures
Notifier: Lallemand Health Solutions
Notifier Address: 17975 rue des Gouverneurs
Mirabel, Quebec, J7J 2K7
GRAS Notice (releasable information): GRN 758 (in PDF) (5.0 MB)
  Part 2: GRN 758 amendments (in PDF) (630 kB)
Date of closure: Aug 20, 2018
FDA's Letter: FDA has no questions (in PDF) (103 kB)